These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 21378384)

  • 1. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
    Auernhammer CJ; Göke B
    Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment strategies in advanced neuroendocrine tumours.
    Walter T; Brixi-Benmansour H; Lombard-Bohas C; Cadiot G
    Dig Liver Dis; 2012 Feb; 44(2):95-105. PubMed ID: 21983252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for gastro-enteropancreatic endocrine tumours.
    O'Toole D; Hentic O; Corcos O; Ruszniewski P
    Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?
    Niederle B; Selberherr A; Niederle MB
    Curr Oncol Rep; 2021 May; 23(7):85. PubMed ID: 34018081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum.
    Niederle B; Pape UF; Costa F; Gross D; Kelestimur F; Knigge U; Öberg K; Pavel M; Perren A; Toumpanakis C; O'Connor J; O'Toole D; Krenning E; Reed N; Kianmanesh R;
    Neuroendocrinology; 2016; 103(2):125-38. PubMed ID: 26758972
    [No Abstract]   [Full Text] [Related]  

  • 8. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
    Ruszniewski P; O'Toole D
    Neuroendocrinology; 2004; 80 Suppl 1():74-8. PubMed ID: 15477722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine tumors of the pancreas.
    Ehehalt F; Saeger HD; Schmidt CM; Grützmann R
    Oncologist; 2009 May; 14(5):456-67. PubMed ID: 19411317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
    Oberg K
    Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of advanced neuroendocrine tumors with hepatic metastasis.
    Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
    J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours.
    Khan MS; Caplin ME
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S53-74. PubMed ID: 22005115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix.
    Nakakura EK
    Ann Surg Oncol; 2018 Mar; 25(3):591-593. PubMed ID: 28779367
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of neuroendocrine tumors of the digestive tract].
    Wada I; Shimizu N; Seto Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for unresectable neuroendocrine liver metastases.
    John BJ; Davidson BR
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic pancreatic neuroendocrine tumors (pNET): placing current findings into perspective.
    Phan AT
    Cancer Treat Rev; 2013 Feb; 39(1):3-9. PubMed ID: 22459199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
    Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease.
    Frilling A; Li J; Malamutmann E; Schmid KW; Bockisch A; Broelsch CE
    Br J Surg; 2009 Feb; 96(2):175-84. PubMed ID: 19160361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroendocrine neoplasms of the distal jejunum and ileum].
    Anlauf M; Sipos B; Boeck I; Baldus SE; Heikaus S; Krausch M; Knoefel WT; Begum N; Goretzki P; Schott M; Auernhammer CJ; Cremer B; Rinke A; Ezziddin S; Fottner C; Pöpperl G; Lahner H; Hörsch D; Gabbert HE; Komminoth P; Perren A; Klöppel G; Wiedenmann B; Pavel M; Pape U
    Pathologe; 2014 May; 35(3):283-93; quiz 294. PubMed ID: 24671468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.